Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes

Immunotherapy has emerged as a powerful approach to cancer treatment. However, immunotherapeutic resistance limits its clinical application. Therefore, identifying immune-resistant factors, which can be targeted by clinically available drugs and it also can be a companion diagnostic marker, is neede...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyo-Jung, Song, Kwon-Ho, Oh, Se Jin, Kim, Suyeon, Cho, Eunho, Kim, Jungwon, Park, Yun gyu, Lee, Kyung-Mi, Yee, Cassian, Song, Seung-Hwa, Chang, Suhwan, Choi, Jungmin, Jung, Sang Taek, Kim, Tae Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019109/
https://www.ncbi.nlm.nih.gov/pubmed/35440620
http://dx.doi.org/10.1038/s41467-022-29611-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019109/
https://www.ncbi.nlm.nih.gov/pubmed/35440620
http://dx.doi.org/10.1038/s41467-022-29611-y

Ejemplares similares